Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project - PubMed (original) (raw)
. 2009 Sep 15;61(9):1194-201.
doi: 10.1002/art.24646.
S Ohrndorf, H Kellner, J Strunk, T M Backhaus, W Hartung, H Sattler, K Albrecht, J Kaufmann, K Becker, H Sörensen, L Meier, G R Burmester, W A Schmidt
Affiliations
- PMID: 19714611
- DOI: 10.1002/art.24646
Free article
Evaluation of a novel 7-joint ultrasound score in daily rheumatologic practice: a pilot project
M Backhaus et al. Arthritis Rheum. 2009.
Free article
Abstract
Objective: To introduce a new standardized ultrasound score based on 7 joints of the clinically dominant hand and foot (German US7 score) implemented in daily rheumatologic practice.
Methods: The ultrasound score included the following joints of the clinically dominant hand and foot: wrist, second and third metacarpophalangeal and proximal interphalangeal, and second and fifth metatarsophalangeal joints. Synovitis and synovial/tenosynovial vascularity were scored semiquantitatively (grade 0-3) by gray-scale (GS) and power Doppler (PD) ultrasound. Tenosynovitis and erosions were scored for presence. The scoring range was 0-27 for GS synovitis, 0-39 for PD synovitis, 0-7 for GS tenosynovitis, 0-21 for PD tenosynovitis, and 0-14 for erosions. Patients with arthritis were examined at baseline and after the start or change of disease-modifying antirheumatic drug (DMARD) and/or tumor necrosis factor alpha (TNFalpha) inhibitor therapy 3 and 6 months later. C-reactive protein level, erythrocyte sedimentation rate, rheumatoid factor, anti-cyclic citrullinated peptide, Disease Activity Score in 28 joints (DAS28), and radiographs of the hands and feet were performed.
Results: One hundred twenty patients (76% women) with rheumatoid arthritis (91%) and psoriatic arthritis (9%) were enrolled. In 52 cases (43%), erosions were seen in radiography at baseline. Patients received DMARDs (41%), DMARDs plus TNFalpha inhibitors (41%), or TNFalpha inhibitor monotherapy (18%). At baseline, the mean DAS28 was 5.0 and the synovitis scores were 8.1 in GS ultrasound and 3.3 in PD ultrasound. After 6 months of therapy, the DAS28 significantly decreased to 3.6 (Delta = 1.4), and the GS and PD ultrasound scores significantly decreased to 5.5 (-32%) and 2.0 (-39%), respectively.
Conclusion: The German US7 score is a viable tool for examining patients with arthritis in daily rheumatologic practice because it significantly reflects therapeutic response.
Similar articles
- The US7 score is sensitive to change in a large cohort of patients with rheumatoid arthritis over 12 months of therapy.
Backhaus TM, Ohrndorf S, Kellner H, Strunk J, Hartung W, Sattler H, Iking-Konert C, Burmester GR, Schmidt WA, Backhaus M. Backhaus TM, et al. Ann Rheum Dis. 2013 Jul;72(7):1163-9. doi: 10.1136/annrheumdis-2012-201397. Epub 2012 Sep 6. Ann Rheum Dis. 2013. PMID: 22956596 Free PMC article. - Usefulness of power Doppler ultrasound for prediction of re-therapy with rituximab in rheumatoid arthritis: a prospective study of longstanding rheumatoid arthritis patients.
Reiche BE, Ohrndorf S, Feist E, Messerschmidt J, Burmester GR, Backhaus M. Reiche BE, et al. Arthritis Care Res (Hoboken). 2014 Feb;66(2):204-16. doi: 10.1002/acr.22103. Arthritis Care Res (Hoboken). 2014. PMID: 23925935 - Development and evaluation of a novel ultrasound score for large joints in rheumatoid arthritis: one year of experience in daily clinical practice.
Hartung W, Kellner H, Strunk J, Sattler H, Schmidt WA, Ehrenstein B, Fleck M, Backhaus M. Hartung W, et al. Arthritis Care Res (Hoboken). 2012 May;64(5):675-82. doi: 10.1002/acr.21574. Arthritis Care Res (Hoboken). 2012. PMID: 22183834 - High-Resolution US of Rheumatologic Diseases.
Taljanovic MS, Melville DM, Gimber LH, Scalcione LR, Miller MD, Kwoh CK, Klauser AS. Taljanovic MS, et al. Radiographics. 2015 Nov-Dec;35(7):2026-48. doi: 10.1148/rg.2015140250. Radiographics. 2015. PMID: 26562235 Review.
Cited by
- The US7 score is sensitive to change in a large cohort of patients with rheumatoid arthritis over 12 months of therapy.
Backhaus TM, Ohrndorf S, Kellner H, Strunk J, Hartung W, Sattler H, Iking-Konert C, Burmester GR, Schmidt WA, Backhaus M. Backhaus TM, et al. Ann Rheum Dis. 2013 Jul;72(7):1163-9. doi: 10.1136/annrheumdis-2012-201397. Epub 2012 Sep 6. Ann Rheum Dis. 2013. PMID: 22956596 Free PMC article. - Contribution of inflammation markers and quantitative sensory testing (QST) indices of central sensitisation to rheumatoid arthritis pain.
Georgopoulos V, Smith S, McWilliams DF, Ferguson E, Wakefield R, Platts D, Ledbury S, Wilson D, Walsh DA. Georgopoulos V, et al. Arthritis Res Ther. 2024 Oct 8;26(1):175. doi: 10.1186/s13075-024-03407-5. Arthritis Res Ther. 2024. PMID: 39380043 Free PMC article. - Analysis of the correlation between disease activity score 28 and its ultrasonographic equivalent in rheumatoid arthritis patients.
Coras R, Sturchio GA, Bru MB, Fernandez AS, Farietta S, Badia SC, Diez BR, de Agustín de Oro JJ. Coras R, et al. Eur J Rheumatol. 2020 Jul;7(3):118-123. doi: 10.5152/eurjrheum.2020.20038. Epub 2020 Jul 21. Eur J Rheumatol. 2020. PMID: 32716834 Free PMC article. - Predicting persistent inflammatory arthritis amongst early arthritis clinic patients in the UK: is musculoskeletal ultrasound required?
Pratt AG, Lorenzi AR, Wilson G, Platt PN, Isaacs JD. Pratt AG, et al. Arthritis Res Ther. 2013;15(5):R118. doi: 10.1186/ar4298. Arthritis Res Ther. 2013. PMID: 24028567 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials